The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
130 jobs Number of planned job creations
Announcement Date
24 November 2014
Employment effect (start)
1 March 2015
Foreseen end date
Description
Sandoz, the generic pharmaceutical division of Novartis, has announced its plan to create 130 new jobs in Stryków. The company uses automated production lines and hence is looking for workers with computer skills. The company has invested PLN 125 million (EUR 30.12 million) since 2013 in Poland and the new production lines will be operational at the beginning of March 2015.
Sandoz has been operating in Poland since 2010 and at its two locations (Warszawa and Stryków) employs currently 1,200 people.
Sources
24 November 2014: Gazeta Wyborcza
Citation
Eurofound (2014), Sandoz, Business expansion in Poland, factsheet number 78660, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/78660.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
